ICH E2D(R1) Guideline on post-approval safety data Step 2b - Revision 1
Submitted by Anonymous (not verified) on 1 March 2024 - 15:36
ICH E2D(R1) Guideline on post-approval safety data Step 2b - Revision 1
List of centrally authorised products requiring a notification of a change for update of annexes
Submitted by Anonymous (not verified) on 1 March 2024 - 13:55
List of centrally authorised products requiring a notification of a change for update of annexes
QRD Appendix III to the Quality Review of Documents templates for human medicinal products (Cover page)
Submitted by Anonymous (not verified) on 1 March 2024 - 11:43
QRD Appendix III to the Quality Review of Documents templates for human medicinal products (Cover page)
Herbal medicinal product: Foeniculi amari fructusArray, F: Assessment finalised
Submitted by Anonymous (not verified) on 1 March 2024 - 11:43
Herbal medicinal product: Foeniculi amari fructusArray, F: Assessment finalised
Herbal medicinal product: Foeniculi dulcis fructusArray, F: Assessment finalised
Submitted by Anonymous (not verified) on 1 March 2024 - 11:43
Herbal medicinal product: Foeniculi dulcis fructusArray, F: Assessment finalised
Human medicines European public assessment report (EPAR): Aldara, imiquimod, Date of authorisation: 18/09/1998, Revision: 32, Status: Authorised
Submitted by Anonymous (not verified) on 1 March 2024 - 10:35
Human medicines European public assessment report (EPAR): Aldara, imiquimod, Date of authorisation: 18/09/1998, Revision: 32, Status: Authorised
Organisation chart: Information Management
Submitted by Anonymous (not verified) on 1 March 2024 - 9:32
Organisation chart: Information Management
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - January 2024, European Medicines Agency, Amsterdam, the Netherlands, 29 January 2024
Submitted by Anonymous (not verified) on 1 March 2024 - 9:13
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - January 2024, European Medicines Agency, Amsterdam, the Netherlands, 29 January 2024
Minutes - Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) (29 January 2024)
Submitted by Anonymous (not verified) on 1 March 2024 - 9:11
Minutes - Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) (29 January 2024)
Shortage of Ixiaro (Japanese encephalitis vaccine (inactivated, adsorbed))
Submitted by Anonymous (not verified) on 1 March 2024 - 8:22
Shortage of Ixiaro (Japanese encephalitis vaccine (inactivated, adsorbed))